id
stringlengths
15
19
document_id
stringlengths
15
19
passages
list
entities
list
events
list
coreferences
list
relations
list
split_0_train_29200
split_0_train_29200
[ { "id": "split_0_train_29200_passage", "type": "progene_text", "text": [ "RESULTS :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_29201
split_0_train_29201
[ { "id": "split_0_train_29201_passage", "type": "progene_text", "text": [ "The QWB-SA and SF-36 were highly correlated ." ], "offsets": [ [ 0, 45 ] ] } ]
[]
[]
[]
[]
split_0_train_29202
split_0_train_29202
[ { "id": "split_0_train_29202_passage", "type": "progene_text", "text": [ "The QWB-SA was systematically related to disease state ." ], "offsets": [ [ 0, 56 ] ] } ]
[]
[]
[]
[]
split_0_train_29203
split_0_train_29203
[ { "id": "split_0_train_29203_passage", "type": "progene_text", "text": [ "Those with no symptomatic evidence had the highest scores followed by those who were stable with no metastatic disease and those with metastatic progression ." ], "offsets": [ [ 0, 158 ] ] } ]
[]
[]
[]
[]
split_0_train_29204
split_0_train_29204
[ { "id": "split_0_train_29204_passage", "type": "progene_text", "text": [ "Similar patterns were found for most SF-36 scales although the SF-36 failed to discriminate between those with no evidence of disease and those with stable disease without metastasis ." ], "offsets": [ [ 0, 184 ] ] } ]
[]
[]
[]
[]
split_0_train_29205
split_0_train_29205
[ { "id": "split_0_train_29205_passage", "type": "progene_text", "text": [ "CONCLUSIONS :" ], "offsets": [ [ 0, 13 ] ] } ]
[]
[]
[]
[]
split_0_train_29206
split_0_train_29206
[ { "id": "split_0_train_29206_passage", "type": "progene_text", "text": [ "Both the QWB-SA and SF-36 perform as expected using German language translations ." ], "offsets": [ [ 0, 82 ] ] } ]
[]
[]
[]
[]
split_0_train_29207
split_0_train_29207
[ { "id": "split_0_train_29207_passage", "type": "progene_text", "text": [ "Although both measures differentiate patients with metastasis from those without symptoms , the QWB-SA better differentiated those with no evidence of disease from those with stable disease without metastasis ." ], "offsets": [ [ 0, 210 ] ] } ]
[]
[]
[]
[]
split_0_train_29208
split_0_train_29208
[ { "id": "split_0_train_29208_passage", "type": "progene_text", "text": [ "Relation between blood pressure variability and carotid artery damage in hypertension : baseline data from the European Lacidipine Study on Atherosclerosis ( ELSA ) ." ], "offsets": [ [ 0, 166 ] ] } ]
[]
[]
[]
[]
split_0_train_29209
split_0_train_29209
[ { "id": "split_0_train_29209_passage", "type": "progene_text", "text": [ "BACKGROUND :" ], "offsets": [ [ 0, 12 ] ] } ]
[]
[]
[]
[]
split_0_train_29210
split_0_train_29210
[ { "id": "split_0_train_29210_passage", "type": "progene_text", "text": [ "Baseline data from the European Lacidipine Study on Atherosclerosis ( ELSA ) have shown that carotid intima - media thickness ( IMT ) is not related to diastolic blood pressure ( BP ) , but that it is related to clinic systolic (S) or pulse pressure ( PP ) and more so to their 24 h average values ." ], "offsets": [ [ 0, 299 ] ] } ]
[]
[]
[]
[]
split_0_train_29211
split_0_train_29211
[ { "id": "split_0_train_29211_passage", "type": "progene_text", "text": [ "The aim of the present study was to determine whether IMT independently relates to additional information obtained through ambulatory BP , in particular to SBP or PP variability ." ], "offsets": [ [ 0, 179 ] ] } ]
[]
[]
[]
[]
split_0_train_29212
split_0_train_29212
[ { "id": "split_0_train_29212_passage", "type": "progene_text", "text": [ "METHODS AND RESULTS : In 1663 hypertensive patients , after a wash - out period from antihypertensive treatment ( mean age 56.2 +/- 7.65 years ) , IMT was assessed from 12 different carotid sites ." ], "offsets": [ [ 0, 197 ] ] } ]
[]
[]
[]
[]
split_0_train_29213
split_0_train_29213
[ { "id": "split_0_train_29213_passage", "type": "progene_text", "text": [ "Ambulatory BP measurements were performed every 15 min ( day ) and every 20 min ( night ) ." ], "offsets": [ [ 0, 91 ] ] } ]
[]
[]
[]
[]
split_0_train_29214
split_0_train_29214
[ { "id": "split_0_train_29214_passage", "type": "progene_text", "text": [ "IMT values were positively related to 24 h , day and night average SBP and PP ." ], "offsets": [ [ 0, 79 ] ] } ]
[]
[]
[]
[]
split_0_train_29215
split_0_train_29215
[ { "id": "split_0_train_29215_passage", "type": "progene_text", "text": [ "There was some relationship of IMT with day - night or clinic - day SBP and PP differences ." ], "offsets": [ [ 0, 92 ] ] } ]
[]
[]
[]
[]
split_0_train_29216
split_0_train_29216
[ { "id": "split_0_train_29216_passage", "type": "progene_text", "text": [ "The most important finding , however , was that IMT values were related with 24 h SBP or PP standard deviation ( P < 0.001 ) , a measure of overall SBP or PP variability ." ], "offsets": [ [ 0, 171 ] ] } ]
[]
[]
[]
[]
split_0_train_29217
split_0_train_29217
[ { "id": "split_0_train_29217_passage", "type": "progene_text", "text": [ "The relationship was seen also by multiple regression analysis , the standard deviation for SBP or PP only following age and 24 h average SBP or PP in accounting for IMT values ." ], "offsets": [ [ 0, 178 ] ] } ]
[]
[]
[]
[]
split_0_train_29218
split_0_train_29218
[ { "id": "split_0_train_29218_passage", "type": "progene_text", "text": [ "CONCLUSIONS : This is the first demonstration from a large database that not only average 24 h PP and SBP values , but also 24 h BP fluctuations , are associated with , and possibly determinants of , the alterations of large artery structure in hypertension ." ], "offsets": [ [ 0, 259 ] ] } ]
[]
[]
[]
[]
split_0_train_29219
split_0_train_29219
[ { "id": "split_0_train_29219_passage", "type": "progene_text", "text": [ "The maternal gene spn-4 encodes a predicted RRM protein required for mitotic spindle orientation and cell fate patterning in early C. elegans embryos ." ], "offsets": [ [ 0, 151 ] ] } ]
[ { "id": "split_0_train_47462_entity", "type": "progene_text", "text": [ "spn-4" ], "offsets": [ [ 18, 23 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29220
split_0_train_29220
[ { "id": "split_0_train_29220_passage", "type": "progene_text", "text": [ "C. elegans embryogenesis begins with a stereotyped sequence of asymmetric cell divisions that are largely responsible for establishing the nematode body plan ." ], "offsets": [ [ 0, 159 ] ] } ]
[]
[]
[]
[]
split_0_train_29221
split_0_train_29221
[ { "id": "split_0_train_29221_passage", "type": "progene_text", "text": [ "These early asymmetries are specified after fertilization by the widely conserved , cortically enriched PAR and PKC-3 proteins , which include three kinases and two PDZ domain proteins ." ], "offsets": [ [ 0, 186 ] ] } ]
[ { "id": "split_0_train_47463_entity", "type": "progene_text", "text": [ "PAR" ], "offsets": [ [ 104, 107 ] ], "normalized": [] }, { "id": "split_0_train_47464_entity", "type": "progene_text", "text": [ "PKC-3" ], "offsets": [ [ 112, 117 ] ], "normalized": [] }, { "id": "split_0_train_47465_entity", "type": "progene_text", "text": [ "kinases" ], "offsets": [ [ 149, 156 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29222
split_0_train_29222
[ { "id": "split_0_train_29222_passage", "type": "progene_text", "text": [ "During asymmetric cell divisions in the early embryo , centrosome pairs initially are positioned on transverse axes but then rotate to align with the anteroposterior embryonic axis ." ], "offsets": [ [ 0, 182 ] ] } ]
[]
[]
[]
[]
split_0_train_29223
split_0_train_29223
[ { "id": "split_0_train_29223_passage", "type": "progene_text", "text": [ "We show that rotation of the centrosomal / nuclear complex in an embryonic cell called P(1) requires a maternally expressed gene we name spn - 4 ." ], "offsets": [ [ 0, 146 ] ] } ]
[ { "id": "split_0_train_47466_entity", "type": "progene_text", "text": [ "spn - 4" ], "offsets": [ [ 137, 144 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29224
split_0_train_29224
[ { "id": "split_0_train_29224_passage", "type": "progene_text", "text": [ "The predicted SPN-4 protein contains a single RNA recognition motif ( RRM ) , and belongs to a small subfamily of RRM proteins that includes one Drosophila and two human family members ." ], "offsets": [ [ 0, 186 ] ] } ]
[ { "id": "split_0_train_47467_entity", "type": "progene_text", "text": [ "SPN-4" ], "offsets": [ [ 14, 19 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29225
split_0_train_29225
[ { "id": "split_0_train_29225_passage", "type": "progene_text", "text": [ "Remarkably , in mutant embryos lacking spn-4 function the transversely oriented ' P(1)' mitotic spindle appears to re - specify the axis of cell polarity , and the division remains asymmetric ." ], "offsets": [ [ 0, 193 ] ] } ]
[ { "id": "split_0_train_47468_entity", "type": "progene_text", "text": [ "spn-4" ], "offsets": [ [ 39, 44 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29226
split_0_train_29226
[ { "id": "split_0_train_29226_passage", "type": "progene_text", "text": [ "spn-4 also is required for other developmental processes , including the specification of mesendoderm , the restriction of mesectoderm fate to P(1) descendants , and germline quiescence during embryogenesis ." ], "offsets": [ [ 0, 208 ] ] } ]
[ { "id": "split_0_train_47469_entity", "type": "progene_text", "text": [ "spn-4" ], "offsets": [ [ 0, 5 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29227
split_0_train_29227
[ { "id": "split_0_train_29227_passage", "type": "progene_text", "text": [ "We suggest that SPN-4 post - transcriptionally regulates the expression of multiple developmental regulators ." ], "offsets": [ [ 0, 110 ] ] } ]
[ { "id": "split_0_train_47470_entity", "type": "progene_text", "text": [ "SPN-4" ], "offsets": [ [ 16, 21 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29228
split_0_train_29228
[ { "id": "split_0_train_29228_passage", "type": "progene_text", "text": [ "Such SPN-4 targets might then act more specifically to generate a subset of the anterior - posterior asymmetries initially specified after fertilization by the more generally required PAR and PKC-3 proteins ." ], "offsets": [ [ 0, 208 ] ] } ]
[ { "id": "split_0_train_47471_entity", "type": "progene_text", "text": [ "SPN-4" ], "offsets": [ [ 5, 10 ] ], "normalized": [] }, { "id": "split_0_train_47472_entity", "type": "progene_text", "text": [ "PAR" ], "offsets": [ [ 184, 187 ] ], "normalized": [] }, { "id": "split_0_train_47473_entity", "type": "progene_text", "text": [ "PKC-3" ], "offsets": [ [ 192, 197 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29229
split_0_train_29229
[ { "id": "split_0_train_29229_passage", "type": "progene_text", "text": [ "Ulcerative colitis and sarcoidosis ." ], "offsets": [ [ 0, 36 ] ] } ]
[]
[]
[]
[]
split_0_train_29230
split_0_train_29230
[ { "id": "split_0_train_29230_passage", "type": "progene_text", "text": [ "A 38 - year - old woman with ulcerative colitis subsequently developed sarcoidosis ." ], "offsets": [ [ 0, 84 ] ] } ]
[]
[]
[]
[]
split_0_train_29231
split_0_train_29231
[ { "id": "split_0_train_29231_passage", "type": "progene_text", "text": [ "After ten years of recurrent episodes of colitis , she had presented with respiratory symptoms ." ], "offsets": [ [ 0, 96 ] ] } ]
[]
[]
[]
[]
split_0_train_29232
split_0_train_29232
[ { "id": "split_0_train_29232_passage", "type": "progene_text", "text": [ "The diagnosis of sarcoidosis was confirmed by mediastinal lymph node biopsy ." ], "offsets": [ [ 0, 77 ] ] } ]
[]
[]
[]
[]
split_0_train_29233
split_0_train_29233
[ { "id": "split_0_train_29233_passage", "type": "progene_text", "text": [ "Her respiratory symptoms gradually resolved without any specific treatment ." ], "offsets": [ [ 0, 76 ] ] } ]
[]
[]
[]
[]
split_0_train_29234
split_0_train_29234
[ { "id": "split_0_train_29234_passage", "type": "progene_text", "text": [ "Within the remission period of sarcoidosis , she underwent uneventful subtotal colectomy due to refractory colitis ." ], "offsets": [ [ 0, 116 ] ] } ]
[]
[]
[]
[]
split_0_train_29235
split_0_train_29235
[ { "id": "split_0_train_29235_passage", "type": "progene_text", "text": [ "Alterations in immune function and genetic susceptibility have been suggested to be present in both ulcerative colitis and sarcoidosis ." ], "offsets": [ [ 0, 136 ] ] } ]
[]
[]
[]
[]
split_0_train_29236
split_0_train_29236
[ { "id": "split_0_train_29236_passage", "type": "progene_text", "text": [ "However , the occurrence of both in the same patient has been rare ." ], "offsets": [ [ 0, 68 ] ] } ]
[]
[]
[]
[]
split_0_train_29237
split_0_train_29237
[ { "id": "split_0_train_29237_passage", "type": "progene_text", "text": [ "This is only the nineteenth case reported in the literature ." ], "offsets": [ [ 0, 61 ] ] } ]
[]
[]
[]
[]
split_0_train_29238
split_0_train_29238
[ { "id": "split_0_train_29238_passage", "type": "progene_text", "text": [ "Dietary boron supplementation enhanced the action of estrogen , but not that of parathyroid hormone , to improve trabecular bone quality in ovariectomized rats ." ], "offsets": [ [ 0, 161 ] ] } ]
[ { "id": "split_0_train_47474_entity", "type": "progene_text", "text": [ "parathyroid hormone" ], "offsets": [ [ 80, 99 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29239
split_0_train_29239
[ { "id": "split_0_train_29239_passage", "type": "progene_text", "text": [ "This study investigated whether boron would enhance the ability of 17beta-estradiol ( E2 ) or parathyroid hormone ( PTH ) to improve bone quality in ovariectomized OVX rats ." ], "offsets": [ [ 0, 174 ] ] } ]
[ { "id": "split_0_train_47475_entity", "type": "progene_text", "text": [ "parathyroid hormone" ], "offsets": [ [ 94, 113 ] ], "normalized": [] }, { "id": "split_0_train_47476_entity", "type": "progene_text", "text": [ "PTH" ], "offsets": [ [ 116, 119 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29240
split_0_train_29240
[ { "id": "split_0_train_29240_passage", "type": "progene_text", "text": [ "Adult OVX rats were treated for 5 wk with vehicle , boron ( 5 ppm as boric acid ) , E2 ( 30 microg / kg / d , sc ) , PTH ( 60 microg / kg / d , sc ) , or a combination of boron and E2 or PTH , respectively ." ], "offsets": [ [ 0, 207 ] ] } ]
[ { "id": "split_0_train_47477_entity", "type": "progene_text", "text": [ "PTH" ], "offsets": [ [ 187, 190 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29241
split_0_train_29241
[ { "id": "split_0_train_29241_passage", "type": "progene_text", "text": [ "The E2 treatment corrected many adverse effects of OVX on bone quality , increased bone Ca , P , and Mg contents , and decreased trabecular plate separation ." ], "offsets": [ [ 0, 158 ] ] } ]
[]
[]
[]
[]
split_0_train_29242
split_0_train_29242
[ { "id": "split_0_train_29242_passage", "type": "progene_text", "text": [ "Dietary boron supplementation had no effects on these bone parameters in OVX rats ." ], "offsets": [ [ 0, 83 ] ] } ]
[]
[]
[]
[]
split_0_train_29243
split_0_train_29243
[ { "id": "split_0_train_29243_passage", "type": "progene_text", "text": [ "When OVX rats were treated with boron and E2 together , trabecular bone volume ( Tb.BS / TV ) and plate density were increased significantly more than that caused by E2 alone ." ], "offsets": [ [ 0, 176 ] ] } ]
[]
[]
[]
[]
split_0_train_29244
split_0_train_29244
[ { "id": "split_0_train_29244_passage", "type": "progene_text", "text": [ "The boron and E2 combination also increased trabecular bone surface ( Tb.BV / TV ) and decreased trabecular plate separation in OVX rats ." ], "offsets": [ [ 0, 138 ] ] } ]
[]
[]
[]
[]
split_0_train_29245
split_0_train_29245
[ { "id": "split_0_train_29245_passage", "type": "progene_text", "text": [ "In contrast , whereas daily PTH injection also increased bone Ca , Mg , and P contents , Tb.BV / TV , Tb.BS / TV , trabecular plate density and thickness , and decreased trabecular plate separation in OVX rats , the combination of boron and PTH had no additional improvement in bone quality over that achieved by PTH alone ." ], "offsets": [ [ 0, 324 ] ] } ]
[ { "id": "split_0_train_47478_entity", "type": "progene_text", "text": [ "PTH" ], "offsets": [ [ 28, 31 ] ], "normalized": [] }, { "id": "split_0_train_47479_entity", "type": "progene_text", "text": [ "PTH" ], "offsets": [ [ 241, 244 ] ], "normalized": [] }, { "id": "split_0_train_47480_entity", "type": "progene_text", "text": [ "PTH" ], "offsets": [ [ 313, 316 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29246
split_0_train_29246
[ { "id": "split_0_train_29246_passage", "type": "progene_text", "text": [ "In summary , this study shows for the first time that boron enhanced the action of E2 , but not that of PTH , to improve trabecular bone quality in OVX rats ." ], "offsets": [ [ 0, 158 ] ] } ]
[ { "id": "split_0_train_47481_entity", "type": "progene_text", "text": [ "PTH" ], "offsets": [ [ 104, 107 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29247
split_0_train_29247
[ { "id": "split_0_train_29247_passage", "type": "progene_text", "text": [ "Psoriasis of the scalp ." ], "offsets": [ [ 0, 24 ] ] } ]
[]
[]
[]
[]
split_0_train_29248
split_0_train_29248
[ { "id": "split_0_train_29248_passage", "type": "progene_text", "text": [ "Diagnosis and management ." ], "offsets": [ [ 0, 26 ] ] } ]
[]
[]
[]
[]
split_0_train_29249
split_0_train_29249
[ { "id": "split_0_train_29249_passage", "type": "progene_text", "text": [ "Psoriasis of the scalp is a frequently occurring condition affecting approximately 2 % of the Western population ." ], "offsets": [ [ 0, 114 ] ] } ]
[]
[]
[]
[]
split_0_train_29250
split_0_train_29250
[ { "id": "split_0_train_29250_passage", "type": "progene_text", "text": [ "The sharply demarcated erythematosquamous lesions with silver - white scaling characterize scalp psoriasis ." ], "offsets": [ [ 0, 108 ] ] } ]
[]
[]
[]
[]
split_0_train_29251
split_0_train_29251
[ { "id": "split_0_train_29251_passage", "type": "progene_text", "text": [ "Quality of life can be seriously reduced by this condition and therefore long term treatment is needed in most patients ." ], "offsets": [ [ 0, 121 ] ] } ]
[]
[]
[]
[]
split_0_train_29252
split_0_train_29252
[ { "id": "split_0_train_29252_passage", "type": "progene_text", "text": [ "Coal tar shampoos , containing 2 to 10 % coal tar solution , are effective in scalp psoriasis ." ], "offsets": [ [ 0, 95 ] ] } ]
[]
[]
[]
[]
split_0_train_29253
split_0_train_29253
[ { "id": "split_0_train_29253_passage", "type": "progene_text", "text": [ "However , no double - blind studies are available to support such an assumption ." ], "offsets": [ [ 0, 81 ] ] } ]
[]
[]
[]
[]
split_0_train_29254
split_0_train_29254
[ { "id": "split_0_train_29254_passage", "type": "progene_text", "text": [ "Salicylic acid 5 to 10 % has a pronounced keratolytic effect ." ], "offsets": [ [ 0, 62 ] ] } ]
[]
[]
[]
[]
split_0_train_29255
split_0_train_29255
[ { "id": "split_0_train_29255_passage", "type": "progene_text", "text": [ "Salicylic acid should be formulated in an ointment , which can be washed off easily ." ], "offsets": [ [ 0, 85 ] ] } ]
[]
[]
[]
[]
split_0_train_29256
split_0_train_29256
[ { "id": "split_0_train_29256_passage", "type": "progene_text", "text": [ "Crude coal tar is the most effective tar available for the treatment of psoriasis ." ], "offsets": [ [ 0, 83 ] ] } ]
[]
[]
[]
[]
split_0_train_29257
split_0_train_29257
[ { "id": "split_0_train_29257_passage", "type": "progene_text", "text": [ "An important feature of coal tar is its potent efficacy against pruritus ." ], "offsets": [ [ 0, 74 ] ] } ]
[]
[]
[]
[]
split_0_train_29258
split_0_train_29258
[ { "id": "split_0_train_29258_passage", "type": "progene_text", "text": [ "At the scalp , the application of crude coal tar is difficult ." ], "offsets": [ [ 0, 63 ] ] } ]
[]
[]
[]
[]
split_0_train_29259
split_0_train_29259
[ { "id": "split_0_train_29259_passage", "type": "progene_text", "text": [ "Therefore coal tar solution is the most frequently applied tar preparation in scalp psoriasis ." ], "offsets": [ [ 0, 95 ] ] } ]
[]
[]
[]
[]
split_0_train_29260
split_0_train_29260
[ { "id": "split_0_train_29260_passage", "type": "progene_text", "text": [ "Dithranol 0.1 to 3 % is manufactured in various formulations ." ], "offsets": [ [ 0, 62 ] ] } ]
[]
[]
[]
[]
split_0_train_29261
split_0_train_29261
[ { "id": "split_0_train_29261_passage", "type": "progene_text", "text": [ "Treatment is initiated at a low concentration and the concentration is increased stepwise until a slight irritation , the feeling of warmth , is reached ." ], "offsets": [ [ 0, 154 ] ] } ]
[]
[]
[]
[]
split_0_train_29262
split_0_train_29262
[ { "id": "split_0_train_29262_passage", "type": "progene_text", "text": [ "In the treatment of scalp psoriasis , cream formulations are used ." ], "offsets": [ [ 0, 67 ] ] } ]
[]
[]
[]
[]
split_0_train_29263
split_0_train_29263
[ { "id": "split_0_train_29263_passage", "type": "progene_text", "text": [ "Imidazole antifungals have been used with success in scalp psoriasis ." ], "offsets": [ [ 0, 70 ] ] } ]
[]
[]
[]
[]
split_0_train_29264
split_0_train_29264
[ { "id": "split_0_train_29264_passage", "type": "progene_text", "text": [ "Overgrowth of the scalp with pityrosporon is a well - known feature of scalp psoriasis and seborrheic dermatitis ." ], "offsets": [ [ 0, 114 ] ] } ]
[]
[]
[]
[]
split_0_train_29265
split_0_train_29265
[ { "id": "split_0_train_29265_passage", "type": "progene_text", "text": [ "In case of resistance to other topical treatments use of a topical or systemic imidazole derivative might be helpful ." ], "offsets": [ [ 0, 118 ] ] } ]
[]
[]
[]
[]
split_0_train_29266
split_0_train_29266
[ { "id": "split_0_train_29266_passage", "type": "progene_text", "text": [ "So far , topical corticosteroids are the most frequently used treatments for psoriasis of the scalp ." ], "offsets": [ [ 0, 101 ] ] } ]
[]
[]
[]
[]
split_0_train_29267
split_0_train_29267
[ { "id": "split_0_train_29267_passage", "type": "progene_text", "text": [ "Corticosteroids inhibit epidermal proliferation , inhibit inflammation and modulate immune functions ." ], "offsets": [ [ 0, 102 ] ] } ]
[]
[]
[]
[]
split_0_train_29268
split_0_train_29268
[ { "id": "split_0_train_29268_passage", "type": "progene_text", "text": [ "Topical corticosteroids are fast acting : within 3 to 4 weeks maximal efficacy is reached ." ], "offsets": [ [ 0, 91 ] ] } ]
[]
[]
[]
[]
split_0_train_29269
split_0_train_29269
[ { "id": "split_0_train_29269_passage", "type": "progene_text", "text": [ "No data are available to support the efficacy and safety of topical corticosteroids during long term use ." ], "offsets": [ [ 0, 106 ] ] } ]
[]
[]
[]
[]
split_0_train_29270
split_0_train_29270
[ { "id": "split_0_train_29270_passage", "type": "progene_text", "text": [ "However , from epidemiologic surveys we know that these treatments are used by the majority of patients for more than 8 weeks ." ], "offsets": [ [ 0, 127 ] ] } ]
[]
[]
[]
[]
split_0_train_29271
split_0_train_29271
[ { "id": "split_0_train_29271_passage", "type": "progene_text", "text": [ "Since 1992 vitamin D3 formulations have been developed for the treatment of psoriasis ." ], "offsets": [ [ 0, 87 ] ] } ]
[]
[]
[]
[]
split_0_train_29272
split_0_train_29272
[ { "id": "split_0_train_29272_passage", "type": "progene_text", "text": [ "Calcipotriol is available in most countries ." ], "offsets": [ [ 0, 45 ] ] } ]
[]
[]
[]
[]
split_0_train_29273
split_0_train_29273
[ { "id": "split_0_train_29273_passage", "type": "progene_text", "text": [ "Tacalcitol is available in Japan and several other countries ." ], "offsets": [ [ 0, 62 ] ] } ]
[]
[]
[]
[]
split_0_train_29274
split_0_train_29274
[ { "id": "split_0_train_29274_passage", "type": "progene_text", "text": [ "Vitamin D3 analogues inhibit epidermal proliferation , enhance cornification and inhibit inflammation ." ], "offsets": [ [ 0, 103 ] ] } ]
[]
[]
[]
[]
split_0_train_29275
split_0_train_29275
[ { "id": "split_0_train_29275_passage", "type": "progene_text", "text": [ "Therefore , vitamin D3 analogues have a substantial antipsoriatic effect ." ], "offsets": [ [ 0, 74 ] ] } ]
[]
[]
[]
[]
split_0_train_29276
split_0_train_29276
[ { "id": "split_0_train_29276_passage", "type": "progene_text", "text": [ "Systemic treatments such as methotrexate , cyclosporine and acitretin are indicated in patients with recalcitrant disease ." ], "offsets": [ [ 0, 123 ] ] } ]
[]
[]
[]
[]
split_0_train_29277
split_0_train_29277
[ { "id": "split_0_train_29277_passage", "type": "progene_text", "text": [ "Management of scalp psoriasis requires long term strategies in order to reach an optimal improvement of the condition , while avoiding the adverse effects associated with the long term use of treatments ." ], "offsets": [ [ 0, 204 ] ] } ]
[]
[]
[]
[]
split_0_train_29278
split_0_train_29278
[ { "id": "split_0_train_29278_passage", "type": "progene_text", "text": [ "Phase II trial of the anti - G(D2) monoclonal antibody 3F8 and granulocyte - macrophage colony - stimulating factor for neuroblastoma ." ], "offsets": [ [ 0, 135 ] ] } ]
[ { "id": "split_0_train_47482_entity", "type": "progene_text", "text": [ "granulocyte - macrophage colony - stimulating factor" ], "offsets": [ [ 63, 115 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29279
split_0_train_29279
[ { "id": "split_0_train_29279_passage", "type": "progene_text", "text": [ "PURPOSE :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_29280
split_0_train_29280
[ { "id": "split_0_train_29280_passage", "type": "progene_text", "text": [ "To describe oncolytic effects of treatment with anti - G(D2) monoclonal antibody 3F8 plus granulocyte - macrophage colony - stimulating factor ( GM-CSF ) in patients with neuroblastoma ( NB ) ." ], "offsets": [ [ 0, 193 ] ] } ]
[ { "id": "split_0_train_47483_entity", "type": "progene_text", "text": [ "granulocyte - macrophage colony - stimulating factor" ], "offsets": [ [ 90, 142 ] ], "normalized": [] }, { "id": "split_0_train_47484_entity", "type": "progene_text", "text": [ "GM-CSF" ], "offsets": [ [ 145, 151 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29281
split_0_train_29281
[ { "id": "split_0_train_29281_passage", "type": "progene_text", "text": [ "PATIENTS AND METHODS :" ], "offsets": [ [ 0, 22 ] ] } ]
[]
[]
[]
[]
split_0_train_29282
split_0_train_29282
[ { "id": "split_0_train_29282_passage", "type": "progene_text", "text": [ "Patients were eligible for 3F8 / GM-CSF if intensive therapy had not eradicated potentially lethal NB ." ], "offsets": [ [ 0, 103 ] ] } ]
[ { "id": "split_0_train_47485_entity", "type": "progene_text", "text": [ "GM-CSF" ], "offsets": [ [ 33, 39 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29283
split_0_train_29283
[ { "id": "split_0_train_29283_passage", "type": "progene_text", "text": [ "One cycle consisted of GM-CSF ( subcutaneous bolus ) on days 1 through 5 , 11 , and 12 , and GM-CSF ( 2 - hour intravenous [ IV ] infusion ) followed after a 1 - hour interval by 3F8 ( 1.5 - hour IV infusion ) on days 6 through 10 and 13 through 17 ." ], "offsets": [ [ 0, 250 ] ] } ]
[ { "id": "split_0_train_47486_entity", "type": "progene_text", "text": [ "GM-CSF" ], "offsets": [ [ 23, 29 ] ], "normalized": [] }, { "id": "split_0_train_47487_entity", "type": "progene_text", "text": [ "GM-CSF" ], "offsets": [ [ 93, 99 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29284
split_0_train_29284
[ { "id": "split_0_train_29284_passage", "type": "progene_text", "text": [ "GM-CSF was dosed at 250 microg / m(2) / d on days 1 through 7 and at 500 microg / m(2) / d on days 8 through 17 ." ], "offsets": [ [ 0, 113 ] ] } ]
[ { "id": "split_0_train_47488_entity", "type": "progene_text", "text": [ "GM-CSF" ], "offsets": [ [ 0, 6 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29285
split_0_train_29285
[ { "id": "split_0_train_29285_passage", "type": "progene_text", "text": [ "3F8 was dosed at 10 mg / m(2) / d ( 100 mg / m(2) / cycle ) ." ], "offsets": [ [ 0, 61 ] ] } ]
[]
[]
[]
[]
split_0_train_29286
split_0_train_29286
[ { "id": "split_0_train_29286_passage", "type": "progene_text", "text": [ "3F8 was given with an opiate and an antihistamine ." ], "offsets": [ [ 0, 51 ] ] } ]
[]
[]
[]
[]
split_0_train_29287
split_0_train_29287
[ { "id": "split_0_train_29287_passage", "type": "progene_text", "text": [ "Patients without progressive disease ( PD ) or elevated human antimouse antibody titers could be treated again beginning 3 weeks after completion of a cycle ." ], "offsets": [ [ 0, 158 ] ] } ]
[]
[]
[]
[]
split_0_train_29288
split_0_train_29288
[ { "id": "split_0_train_29288_passage", "type": "progene_text", "text": [ "RESULTS :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_29289
split_0_train_29289
[ { "id": "split_0_train_29289_passage", "type": "progene_text", "text": [ "Among 19 patients treated for NB resistant to induction therapy , 12 of 15 had complete remission ( CR ) of bone marrow ( BM ) disease , and three others who had less than partial responses achieved prolonged progression - free survival ( one remains on study at 21 + months , two had PD at 12 and 17 months ) ." ], "offsets": [ [ 0, 311 ] ] } ]
[]
[]
[]
[]
split_0_train_29290
split_0_train_29290
[ { "id": "split_0_train_29290_passage", "type": "progene_text", "text": [ "Among patients treated for recurrent NB resistant to retrieval therapy , five of 10 had CR in BM ." ], "offsets": [ [ 0, 98 ] ] } ]
[]
[]
[]
[]
split_0_train_29291
split_0_train_29291
[ { "id": "split_0_train_29291_passage", "type": "progene_text", "text": [ "The 15 patients treated for PD fared poorly , although two had scintigraphic findings suggestive of a short - term response ." ], "offsets": [ [ 0, 125 ] ] } ]
[]
[]
[]
[]
split_0_train_29292
split_0_train_29292
[ { "id": "split_0_train_29292_passage", "type": "progene_text", "text": [ "Side effects were limited to readily manageable pain and , less commonly , rash of short duration ; hence , patients were treated as outpatients ." ], "offsets": [ [ 0, 146 ] ] } ]
[]
[]
[]
[]
split_0_train_29293
split_0_train_29293
[ { "id": "split_0_train_29293_passage", "type": "progene_text", "text": [ "CONCLUSION :" ], "offsets": [ [ 0, 12 ] ] } ]
[]
[]
[]
[]
split_0_train_29294
split_0_train_29294
[ { "id": "split_0_train_29294_passage", "type": "progene_text", "text": [ "3F8 / GM-CSF is well tolerated and shows promise for treatment of minimal residual NB in BM ." ], "offsets": [ [ 0, 93 ] ] } ]
[ { "id": "split_0_train_47489_entity", "type": "progene_text", "text": [ "GM-CSF" ], "offsets": [ [ 6, 12 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_29295
split_0_train_29295
[ { "id": "split_0_train_29295_passage", "type": "progene_text", "text": [ "Oculomotor function in the rhesus monkey after deafferentation of the extraocular muscles ." ], "offsets": [ [ 0, 91 ] ] } ]
[]
[]
[]
[]
split_0_train_29296
split_0_train_29296
[ { "id": "split_0_train_29296_passage", "type": "progene_text", "text": [ "The function of extraocular muscle proprioception in the control of eye movements remains uncertain ." ], "offsets": [ [ 0, 101 ] ] } ]
[]
[]
[]
[]
split_0_train_29297
split_0_train_29297
[ { "id": "split_0_train_29297_passage", "type": "progene_text", "text": [ "In this study , we examined the effect of bilateral proprioceptive deafferentation of the extraocular muscles on eye movements in two rhesus monkeys ." ], "offsets": [ [ 0, 150 ] ] } ]
[]
[]
[]
[]
split_0_train_29298
split_0_train_29298
[ { "id": "split_0_train_29298_passage", "type": "progene_text", "text": [ "Before and after deafferentation , we analyzed baseline ocular alignment , saccades , pursuit , and vestibular eye movements ." ], "offsets": [ [ 0, 126 ] ] } ]
[]
[]
[]
[]
split_0_train_29299
split_0_train_29299
[ { "id": "split_0_train_29299_passage", "type": "progene_text", "text": [ "We also examined visually mediated adaptation of ocular alignment , saccades , and pursuit ." ], "offsets": [ [ 0, 92 ] ] } ]
[]
[]
[]
[]